Shares in Sequenom gained more than 16 percent for the 5-day trading period ended Tuesday. The firm’s shares rose after news on Monday that it had signed a pact with Qiagen under which the firms will collaborate on developing prenatal diagnostics (see related article).
Cepheid led decliners for the week with a 7.65 percent drop, despite no new news regarding the company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.